Black Diamond Therapeutics, Inc.
BDTXNasdaqCIK 1701541HealthcareFiscal year ends Dec 31
Reports and events: 107 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-0516:04 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001701541-26-000025 |
| 2026-08-0516:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-26-000023 |
| 2026-06-2916:20 ET | 8-K | 5.07 Shareholder vote results | 0001104659-26-078847 |
| 2026-05-2117:19 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-26-065254 |
| 2026-05-0707:20 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001701541-26-000017 |
| 2026-05-0707:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-26-000015 |
| 2026-04-2916:03 ET | DEF 14A | Proxy statementPeriod 2026-06-26 | 0001104659-26-051474 |
| 2026-03-1616:03 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001701541-26-000009 |
| 2026-03-1616:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-26-000008 |
| 2025-12-0308:20 ET | 8-K | 2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-25-117975 |
| 2025-11-0607:12 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001701541-25-000039 |
| 2025-11-0607:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000038 |
| 2025-08-0707:04 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001701541-25-000030 |
| 2025-08-0707:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000029 |
| 2025-06-1216:19 ET | 8-K | 5.07 Shareholder vote results | 0001104659-25-058893 |
| 2025-05-1216:08 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001701541-25-000022 |
| 2025-05-1216:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000021 |
| 2025-04-1816:01 ET | DEF 14A | Proxy statementPeriod 2025-06-12 | 0001104659-25-036339 |
| 2025-03-1907:08 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-25-025338 |
| 2025-03-0616:03 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001701541-25-000016 |
| 2025-03-0616:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-25-000014 |
| 2024-11-0507:03 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001701541-24-000042 |
| 2024-11-0507:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000040 |
| 2024-10-0716:13 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-106676 |
| 2024-09-2307:09 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-101874 |
| 2024-08-0816:48 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-24-197045 |
| 2024-08-0607:04 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001701541-24-000030 |
| 2024-08-0607:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000028 |
| 2024-06-0616:06 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001104659-24-069070 |
| 2024-05-1319:09 ET | SC 13D/A | Ownership report, active investor, amended | 0001072613-24-000469 |
| 2024-05-0920:48 ET | SC 13D/A | Ownership report, active investor, amended | 0001104659-24-059533 |
| 2024-05-0907:13 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001701541-24-000022 |
| 2024-05-0907:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000020 |
| 2024-04-2416:01 ET | DEF 14A | Proxy statementPeriod 2024-06-06 | 0001104659-24-051211 |
| 2024-04-1108:03 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-046096 |
| 2024-03-1207:20 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001701541-24-000011 |
| 2024-03-1207:17 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-24-000009 |
| 2024-01-1816:04 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001104659-24-004802 |
| 2024-01-0408:07 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-24-001155 |
| 2023-12-1307:08 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-125566 |
| 2023-11-0917:24 ET | SC 13D/A | Ownership report, active investor, amended | 0001193125-23-274632 |
| 2023-11-0607:14 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001701541-23-000047 |
| 2023-11-0607:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-23-000045 |
| 2023-09-1807:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-101377 |
| 2023-08-1107:26 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001701541-23-000041 |
| 2023-08-1107:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001701541-23-000039 |
| 2023-06-3016:03 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001104659-23-077061 |
| 2023-06-2707:11 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-23-074995 |
| 2023-05-1617:26 ET | 8-K | 5.07 Shareholder vote results | 0001104659-23-061486 |
| 2023-05-0907:45 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001701541-23-000032 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:07 ET. Listed shows no prices and gives no investment advice.